RecruitingNCT06642675
This study is comparing Intermittent theta burst stimulation(iTBS) with control group: sham iTBS for people with Schizophrenia. Participants receive Intermittent theta burst stimulation(iTBS) or control group: sham iTBS and complete study visits and assessments.
SchizophreniaOtherUp to 60 Years
- Countries
- China
- Sponsor
- Central South University
- Condition
- Schizophrenia
Not Yet RecruitingNCT07266376
This study is comparing Integrative group therapy with Media-workshop control group for people with Mental Disorder or Schizophrenia Diagnosis. Participants receive Integrative group therapy or Media-workshop control group and complete study visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de la Guadeloupe
- Condition
- Schizophrenia
RecruitingNCT07265180
This study is comparing Oxytocin with placebo for people with Schizophrenia Spectrum Disorders. Participants receive Oxytocin or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Schizophrenia
Active Not RecruitingNCT06539780
This study is looking at test the effect of imagery rescripting (ImRs) in early psychosis for people with Psychosis, Schizophrenia, or Psychoses, Traumatic. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 16 Years to 45 Years
- Countries
- Netherlands
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Condition
- Schizophrenia
Not Yet RecruitingNCT07252206
This study is looking at whether questionnaires and follow-up can help people with Psychosis or Schizophrenia Spectrum Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia
Not Yet RecruitingNCT06474286
This study is looking at whether Prucalopride 1 MG can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- India
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
Not Yet RecruitingNCT07252752
This study is comparing Intranasal Insulin with placebo for people with First Episode Psychosis. Participants receive Intranasal Insulin or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Austria
- Sponsor
- Medical University of Vienna
- Condition
- Schizophrenia
RecruitingNCT07093671
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 14 Years to 30 Years
- Countries
- Switzerland
- Sponsor
- Marco Armando
- Condition
- Schizophrenia
RecruitingNCT07058389
This study is looking at whether a digital support tool can help people with schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
Active Not RecruitingNCT05112432
This study is looking at whether psychoeducation can help people with Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 15 Years to 40 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
RecruitingNCT06581302
This study is looking at whether Magnetic seizure therapy by Magnetic stimulator can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- China
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Condition
- Schizophrenia
RecruitingNCT05131035
This study is looking at whether SCORES (Specific COgnitive Remediation with Support) can help people with Psychosis, Prodromal Schizophrenia, or Prodromal Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 14 Years to 20 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
Not Yet RecruitingNCT07245212
This study is looking at whether cognitive behavioural therapy can help people with Psychosis, Cannabis Use Disorder, or First Episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
RecruitingNCT05813457
This study is looking at whether a digital support tool can help people with Psychotic Episode. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT07196423
This study is looking at whether a digital support tool can help people with First Episode Psychosis or Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- University of Nottingham
- Condition
- Schizophrenia
RecruitingNCT07234708
This study is looking at whether Sentirnos Seguros can help people with Schizophrenia and Schizophrenia Spectrum Psychosis. Participants take part in Sentirnos Seguros and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Condition
- Schizophrenia
RecruitingNCT06634641
This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Condition
- Schizophrenia
RecruitingNCT07230652
This study is comparing LY03020 with placebo for people with Schizophrenia or Alzheimer's Disease Psychosis. Participants receive LY03020 or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Luye Pharma Group Ltd.
- Condition
- Schizophrenia
RecruitingNCT05500001
This observational study is following people with psychosis, Family Members, Anosognosia, or Paranoia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 17 Years to 27 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Schizophrenia
RecruitingNCT06674694
This study is looking at whether Brexpiprazole long-acting injection can help people with Schizophrenia Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
- Condition
- Schizophrenia
RecruitingNCT07227818
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Schizophrenia
Active Not RecruitingNCT05968638
This study is looking at whether Regular Diet can help people with Schizophrenia or Schizo Affective Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
RecruitingNCT06138054
This study is comparing MI-CBTech with Mindfulness control for people with psychosis. Participants receive MI-CBTech or Mindfulness control and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
RecruitingNCT07119268
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia and Related Disorders or Sleep Disturbance. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Indiana University
- Condition
- Schizophrenia
Active Not RecruitingNCT06251193
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or schizoaffective disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherOver 60 Years
- Countries
- Canada, United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia